Yu Peng

Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer

Yi Qing, Qing Li, Tao Ren et al. · Drug Design Development and Therapy · 2015 · 172 citations · Full text

Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells

Dingguo Wu, Yu Peng, Jianwei Li et al. · Toxicology Letters · 2013 · 73 citations

Cancer Research, Pancreatic Cancer, Medicine +12

Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy

Zheng Li, Yi Qing, Wei Guan et al. · Cancer Chemotherapy and Pharmacology · 2014 · 63 citations

Tubb3 Expression, Medicine, Cancer Cell Biology +9

The regulatory role of APE1 in epithelial‐to‐mesenchymal transition and in determining EGFR‐TKI responsiveness in non‐small‐cell lung cancer

Xiao Yang, Yu Peng, Xuan Jiang et al. · Cancer Medicine · 2018 · 43 citations · Full text

PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer

Qing Li, Zhiwei Zhou, Lu Jia et al. · Molecular Therapy · 2021 · 33 citations · Full text